FDA Discuss Risks of Power Morcellators
Devices raises substantial safety concerns as they can spread a hidden cancer. A U.S. Food and Drug Administration (FDA) expert panel will weigh the risks versus benefits of power morcellators, that are used for minimally invasive hysterectomies. Recently, the devices have raised substantial safety concerns because they can spread a … [Read more...] about FDA Discuss Risks of Power Morcellators
FDA Metal-on-Metal Hip Replacement Safety Meeting Enters Day Two
A panel of advisors for the U.S. Food & Drug Administration (FDA) is preparing to make recommendations regarding the safety of metal-on-metal hip implants. The panel is in its second day of deliberations, and is expected to vote on specific recommendations later today. According to a report from The Wall Street Journal, the … [Read more...] about FDA Metal-on-Metal Hip Replacement Safety Meeting Enters Day Two
The Acreage Cancer Cluster Meeting Yields Few Answers
Meeting On Possible Acreage Cancer Cluster. Few residents of The Acreage who attended a meeting on a possible cancer cluster in the Florida community were satisfied with what they heard. According to a report in The Miami Herald, many attendees were unhappy that an investigator from the Florida Department of Health was unable to … [Read more...] about The Acreage Cancer Cluster Meeting Yields Few Answers
Controversy Swirls Around FDA Meeting on Drug Coated Stents
FDA Review The Use of Drug Coated Stents. A planned FDA safety review regarding the use of drug-coated stents is facing intense scrutiny after it was revealed that six doctors on the advisory panel have financial links to stent makers Johnson & Johnson and Boston Scientific. The meeting, set for Thursday and Friday of … [Read more...] about Controversy Swirls Around FDA Meeting on Drug Coated Stents
Controversy Swirls Around FDA Meeting on Stents
FDA Safety Review The Use Of Drug-Coated Stents. A planned FDA safety review regarding the use of drug-coated stents is facing intense scrutiny after it was revealed that six doctors on the advisory panel have financial links to stent makers Johnson & Johnson and Boston Scientific. The meeting, set for Thursday and Friday of this … [Read more...] about Controversy Swirls Around FDA Meeting on Stents
